End-of-day quote
Bucharest S.E.
03:30:00 05/07/2024 am IST
5-day change
1st Jan Change
0.802
RON
+1.01%
+0.50%
-2.67%
Biofarm S A : 2024 06 03 Current Report
June 03, 2024 at 07:52 pm IST
cod JA-F002-rev01
Translation from Romanian
Biofarm output number: 221/03.06.2024
CURRENT REPORT
according to the F.S.A. Regulation No. 5/2018
Date of the report: 03.06.2024
Name of the Commercial company: BIOFARM S.A.
Registered office: Bucharest, str. Logofatul Tautu, nr. 99, sector 3
Telephone No.: 021/301.06.87
Fax No.: 021/316.52.48
Website: www.biofarm.ro
Unique registration code: RO 341563
Order No. with the Trade Register: J40/199/1991
Fully paid-up share capital: lei 98,537,535
Market on which company securities are traded - Bucharest Stock Exchange, BIO symbol
Important event to report :
Dispute in which the company is involved
The Board of Directors of BIOFARM S.A. informs the shareholders regarding the disputes below with hearings in May 2024 :
FILE NO.
PARTIES
COURT
STAGE
OBJECT
REMARKS
CURRENT TRIAL DATE
NEXT TRIAL
DATE
1
3278/62/2020
Sanosan
Brasov Court
Merits
Insolvency
Biofarm
S.A.
requested
the
At the trial date of 23.05.2024, the
24-10-2024
Pharmaceuticals
of Law
proceedings
opening
of
the
insolvency
court granted administrative term
S.R.L.- Debtor
procedure
against
the
debtor
of control for 24.10.2024, without
Sanosan Pharmaceuticals,
in
the
the participation of the parties, for
Biofarm -
file 1484/62/2020, asking for the
the continuation of the liquidation
Creditor
registration in the table of
procedure, dispute resolution and
creditors with the amount of
debt recovery.
8,066,750.88 lei (main debit and
delay penalties). As the debtor
also filed for insolvency, the court
ordered the connection of the file
1484/62/2020
to
the
main
application (considering Biofarm's
application as a declaration of
registration as a creditor), which
forms the object of the file
3278/62/2020 on the role of
Brasov Court of Law.
99 Logofătul Tăutu Street, District 3, Bucharest, Romania, 031212
T: +40 21 301 0600; F: +40 21 301 0605; Email: office@biofarm.ro; biofarm.ro
Share capital 98.537.535 lei, fully subscribed and paid-up, RO341563, J40/199/5.02.1991
Account RO26 BRDE 441 SV 28095 174410, BRD Unirii Branch
cod JA-F002-rev01
2
597/1371/2017
Farmacordis
Mures
Merits
Insolvency
At the trial term of 30.05.2024, the
24-10-2024
Warehouse
Specialised
proceedings
Biofarm S.A. is registered in the
court established the next trial
S.R.L. - Debtor
Court of Law
debtor's list of creditors with the
term for 24.10.2024 for the
amount of lei 656,506.18 lei,
continuation
of
the proceedings
Biofarm -
being an unsecured creditor.
within the procedure.
Creditor
3
32202/3/2018
Servelectro
Court of Law
Insolvency
At the trial term of 31.05.2024, the
08-11-2024
Integral S.R.L.-
of Bucharest
Merits
Biofarm S.A. is registered in the
court postponed
the case
for
proceedings
Debtor
Municipality
debtor's list of creditors with the
08.11.2024
to
implement
the
amount of lei 333.739 lei, being an
reorganization plan.
Biofarm -
unsecured creditor.
Creditor
B.D. CHAIRMAN
HREBENCIUC Andrei
99 Logofătul Tăutu Street, District 3, Bucharest, Romania, 031212
T: +40 21 301 0600; F: +40 21 301 0605; Email: office@biofarm.ro; biofarm.ro
Share capital 98.537.535 lei, fully subscribed and paid-up, RO341563, J40/199/5.02.1991
Account RO26 BRDE 441 SV 28095 174410, BRD Unirii Branch
Attachments
Original Link
Original Document
Permalink
Disclaimer
BIOFARM SA published this content on
03 June 2024 and is solely responsible for the information contained therein. Distributed by
Public , unedited and unaltered, on
03 June 2024 14:21:06 UTC .
Biofarm S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024
14/05
CI
Biofarm S.A. Reports Earnings Results for the Full Year Ended December 31, 2023
28/02
CI
Biofarm S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023
14/11
CI
Biofarm S.A. Reports Earnings Results for the Half Year Ended June 30, 2023
11/23/11
CI
Biofarm S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023
12/23/12
CI
Biofarm S.A. Reports Earnings Results for the Full Year Ended December 31, 2022
24/23/24
CI
Biofarm S.A. Reports Earnings Results for the Nine Months Ended September 30, 2022
14/22/14
CI
Biofarm S.A. Reports Earnings Results for the Half Year Ended June 30, 2022
12/22/12
CI
Biofarm S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022
13/22/13
CI
Biofarm S.A. Reports Earnings Results for the Full Year Ended December 31, 2021
25/22/25
CI
Biofarm S.A. Reports Earnings Results for the Nine Months Ended September 30, 2021
15/21/15
CI
Biofarm S.A. Reports Earnings Results for the Half Year Ended June 30, 2021
13/21/13
CI
Biofarm S.A. Reports Earnings Results for the First Quarter Ended March 31, 2021
14/21/14
CI
Biofarm S.A. Reports Earnings Results for the Full Year Ended December 31, 2020
15/21/15
CI
Biofarm S.A. Reports Earnings Results for the Nine Months Ended September 30, 2020
13/20/13
CI
Biofarm S.A. Reports Earnings Results for the Half Year Ended June 30, 2020
13/20/13
CI
Biofarm S.A. Announces Dividend for 2019, Payable on September 3, 2020
10/20/10
CI
Biofarm S.A. Reports Earnings Results for the First Quarter Ended March 31, 2020
14/20/14
CI
Biofarm Reports Earnings Results for the First Quarter of 2016
17/16/17
CI
S.C. Biofarm S. A. Reports Sales Results for the First Quarter of 2016
12/16/12
CI
Biofarm Reports Earnings Results for the Year 2015
17/16/17
CI
Biofarm Reports Earnings Results for the First Quarter of 2015
15/15/15
CI
Biofarm Announces Earnings Results for the First Nine Months of 2014
17/14/17
CI
Tranche Update on BioFarm SA's Equity Buyback Plan announced on April 18, 2014.
17/14/17
CI
BioFarm SA's Equity Buyback announced on April 18, 2014, has closed with 109,486,149 shares, representing 10% for RON 33.4 million.
15/14/15
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Biofarm SA is a Romania-based company engaged in the pharmaceutical sector. The Company focuses on the production and marketing of pharmaceutical preparations. The Company is active in the manufacture and wholesale of over the counter drugs, prescription medications and dietary supplements. The Companyâs product portfolio includes pharmaceutical preparations for digestive system, musculoskeletal system, immune stimulation, respiratory system, cold and flu symptoms and venous circulation improvement, as well as multivitamins, antioxidants, antiseptics, disinfectants and cosmetics, among others. Additionally, the Company offers services, such as consultancy on Romanian pharmaceutical market, manufacturing of non-sterile products, the investment in research, promotion and packaging. The main shareholder of the Company is Societatea de Investitii Financiare Muntenia SA.
More about the company
1st Jan change
Capi.
-2.67% 170M +24.53% 44.76B +30.99% 23.16B +24.13% 16.02B +21.15% 14.32B +68.67% 13.7B -0.05% 6.79B -13.29% 6.47B -8.87% 5.73B +13.53% 5.65B
Generic Pharmaceuticals
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1